480 related articles for article (PubMed ID: 29103987)
1. Special radiobiological features of second cancer risk after particle radiotherapy.
Trott KR
Phys Med; 2017 Oct; 42():221-227. PubMed ID: 29103987
[TBL] [Abstract][Full Text] [Related]
2. Risk assessment for cancer induction after low- and high-LET therapeutic irradiation.
Engels H; Menzel HG; Pihet P; Wambersie A
Strahlenther Onkol; 1999 Jun; 175 Suppl 2():47-51. PubMed ID: 10394397
[TBL] [Abstract][Full Text] [Related]
3. The risk of second primary cancers due to peripheral photon and neutron doses received during prostate cancer external beam radiation therapy.
Bezak E; Takam R; Yeoh E; Marcu LG
Phys Med; 2017 Oct; 42():253-258. PubMed ID: 28302493
[TBL] [Abstract][Full Text] [Related]
4. Relative biological effectiveness of neutrons for cancer induction and other late effects: a review of radiobiological data.
Engels H; Wambersie A
Recent Results Cancer Res; 1998; 150():54-87. PubMed ID: 9670283
[TBL] [Abstract][Full Text] [Related]
5. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
6. An estimate of the radiation-induced cancer risk from the whole-body stray radiation exposure in neutron radiotherapy.
Geraci JP; Jackson KL; Mariano MS
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1187-95. PubMed ID: 6761135
[TBL] [Abstract][Full Text] [Related]
7. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
Jones B
J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
[TBL] [Abstract][Full Text] [Related]
8. Out-of-field neutron and leakage photon exposures and the associated risk of second cancers in high-energy photon radiotherapy: current status.
Takam R; Bezak E; Marcu LG; Yeoh E
Radiat Res; 2011 Oct; 176(4):508-20. PubMed ID: 21756083
[TBL] [Abstract][Full Text] [Related]
9. Risk of second cancer after ion beam radiotherapy: insights from animal carcinogenesis studies.
Imaoka T; Nishimura M; Daino K; Takabatake M; Moriyama H; Nishimura Y; Morioka T; Shimada Y; Kakinuma S
Int J Radiat Biol; 2019 Oct; 95(10):1431-1440. PubMed ID: 30495977
[No Abstract] [Full Text] [Related]
10. The ANDANTE project: a multidisciplinary approach to neutron RBE.
Ottolenghi A; Baiocco G; Smyth V; Trott K;
Radiat Prot Dosimetry; 2015 Sep; 166(1-4):311-5. PubMed ID: 25870432
[TBL] [Abstract][Full Text] [Related]
11. MONTE CARLO SIMULATION OF OUT-OF-FIELD ORGAN DOSES AND CANCER RISK IN TANZANIA FOR RADIATION THERAPY OF UNILATERAL RETINOBLASTOMA USING A 60Co UNIT.
Suleiman SA; Qi Y; Pi Y; George Xu X
Radiat Prot Dosimetry; 2018 May; 179(3):263-270. PubMed ID: 29216393
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiation therapy, protons, and the risk of second cancers.
Hall EJ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):1-7. PubMed ID: 16618572
[TBL] [Abstract][Full Text] [Related]
13. A critical evaluation of secondary cancer risk models applied to Monte Carlo dose distributions of 2-dimensional, 3-dimensional conformal and hybrid intensity-modulated radiation therapy for breast cancer.
Joosten A; Bochud F; Moeckli R
Phys Med Biol; 2014 Aug; 59(16):4697-722. PubMed ID: 25082795
[TBL] [Abstract][Full Text] [Related]
14. Risk of secondary cancers: Bridging epidemiology and modeling.
Schneider U; Walsh L
Phys Med; 2017 Oct; 42():228-231. PubMed ID: 28363341
[TBL] [Abstract][Full Text] [Related]
15. Estimation of Second Primary Cancer Risk After Treatment with Radioactive Iodine for Differentiated Thyroid Carcinoma.
Corrêa NL; de Sá LV; de Mello RC
Thyroid; 2017 Feb; 27(2):261-270. PubMed ID: 27762670
[TBL] [Abstract][Full Text] [Related]
16. An historical survey of radiobiology and radiotherapy with fast neutrons.
Field SB
Curr Top Radiat Res Q; 1976 Jan; 11(1):1-86. PubMed ID: 1106959
[TBL] [Abstract][Full Text] [Related]
17. Uncomplicated and Cancer-Free Control Probability (UCFCP): A new integral approach to treatment plan optimization in photon radiation therapy.
Sánchez-Nieto B; Romero-Expósito M; Terrón JA; Sánchez-Doblado F
Phys Med; 2017 Oct; 42():277-284. PubMed ID: 28392313
[TBL] [Abstract][Full Text] [Related]
18. Photons - Radiobiological issues related to the risk of second malignancies.
Marcu LG
Phys Med; 2017 Oct; 42():213-220. PubMed ID: 28236557
[TBL] [Abstract][Full Text] [Related]
19. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma.
Brodin NP; Munck Af Rosenschöld P; Aznar MC; Kiil-Berthelsen A; Vogelius IR; Nilsson P; Lannering B; Björk-Eriksson T
Acta Oncol; 2011 Aug; 50(6):806-16. PubMed ID: 21767178
[TBL] [Abstract][Full Text] [Related]
20. The effect of radiation quality on the risks of second malignancies.
Manem VS; Kohandel M; Hodgson DC; Sharpe MB; Sivaloganathan S
Int J Radiat Biol; 2015 Mar; 91(3):209-17. PubMed ID: 25356906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
